My enemy’s enemy is my… enemy?

Like a kind of Russian doll infection, a prolific human parasite—responsible for almost 250 million infections annually—can itself harbour a parasite, a virus. You might reasonably feel a sense of something akin to schadenfreude; glad it’s getting a dose of its own medicine, so to speak… But you may be too hasty. The very presence of this virus—though it doesn’t infect human cells—in its parasite host could be making infections worse, or even stymying our attempts at  relieving the infection. The parasite in question, with around 3.7 million people infected in the US alone, is the most common protozoan infection in the industrialised world: Trichomonas vaginalis (TrV). It infects the human genitourinary tract of both men and women causing Trichomoniasis; in fact, it can only live in the human genitourinary tract (an ‘obligate human parasite’). Women are more likely to experience symptoms than men, and while generally mild,  it can be bad. Its ...(Read More)

Waking the (Tiny) giant…

Nestled safely away within your cells, among your DNA, lies something…foreign. An invader. Something you weren’t born with, hidden, evading your immune system and waiting to make its next strike: a ‘latent’ virus. In all probability, there are armies of different viruses performing this same trick throughout your body. Remaining silent; some of their own mysterious accord, others kept in check by your immune system or by random mutations, rendering them useless. Now researchers at The Ohio State University and the University of Oxford have worked out how some of these viruses can reactivate in healthy people, and once again go about their nefarious mindless deeds: hijacking our cells machinery, producing more of their own kind, and causing disease. An inefficient virus kills its host. A clever virus stays with it. — James Lovelock In healthy people latent viruses aren’t generally a problem, occasionally annoying, but rarely life threatening. However, ...(Read More)

Finding the un-natural in the lab…

Taming the power of the immune system in the lab wasn’t easy. For a start, it was a mystery how we have so many different antibodies, millions at any one time. But if it’s one gene per protein, and we only had something like 30,000 genes, how could we have millions of different antibodies? Understanding this problem was the key that unlocked one way to make antibodies against targets that we select. We can use them as tools in the lab, or to treat disease—therapeutic antibodies. Chances are you may know someone who has, or is, using them; if they have Crohn’s disease for example. Just finding antibodies that stick to a target—some unique bump, crevice or corner on a virus, for example—isn’t enough. The next step is to find out if they do something useful. They may stick but not prevent infection, or not activate some receptor on a ...(Read More)